Use of Erythropoiesis-Stimulating Agents Among Chemotherapy Patients With Hemoglobin Exceeding 12 Grams Per Deciliter

BACKGROUND: Prior to 2007, the erythropoiesis-stimulating agents (ESAs) epoetin alfa and darbepoetin alfa were indicated for use in chemotherapy induced anemia to achieve target hemoglobin (Hb) levels of approximately 12 grams per deciliter (gm per dL), and treatment was to be withheld if Hb exceede...

Descripción completa

Detalles Bibliográficos
Autores principales: Nordstrom, Beth L., Luo, Weixiu, Fraeman, Kathy H., Whyte, Joanna L., Nordyke, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438319/
https://www.ncbi.nlm.nih.gov/pubmed/19006442
http://dx.doi.org/10.18553/jmcp.2008.14.9.858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438319/
https://www.ncbi.nlm.nih.gov/pubmed/19006442
http://dx.doi.org/10.18553/jmcp.2008.14.9.858

Ejemplares similares